Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 35
2017 287
2018 404
2019 464
2020 160
Text availability
Article attribute
Article type
Publication date

Search Results

1,350 results
Results by year
Filters applied: . Clear all
Page 1
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK. Neunert C, et al. Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966. Blood Adv. 2019. PMID: 31794604 Free PMC article.
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Provan D, et al. Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812. Blood Adv. 2019. PMID: 31770441 Free PMC article.
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.
Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A. Bohlius J, et al. Blood Adv. 2019 Apr 23;3(8):1197-1210. doi: 10.1182/bloodadvances.2018030387. Blood Adv. 2019. PMID: 30971397 Free PMC article. Review.
Emicizumab use in major orthopedic surgery.
Seaman CD, Ragni MV. Seaman CD, et al. Blood Adv. 2019 Jun 11;3(11):1722-1724. doi: 10.1182/bloodadvances.2019000228. Blood Adv. 2019. PMID: 31171509 Free PMC article.
Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs.
Jain P, Kantarjian H, Boddu PC, Nogueras-González GM, Verstovsek S, Garcia-Manero G, Borthakur G, Sasaki K, Kadia TM, Sam P, Ahaneku H, O'Brien S, Estrov Z, Ravandi F, Jabbour E, Cortes JE. Jain P, et al. Blood Adv. 2019 Mar 26;3(6):851-861. doi: 10.1182/bloodadvances.2018025874. Blood Adv. 2019. PMID: 30885996 Free PMC article. Clinical Trial.
1,350 results
Jump to page
Feedback